Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

664
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
664
Gene Therapy00:59

Gene Therapy

25.9K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.9K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

346
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
346

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Altered Static and Dynamic Functional Motor Networks in Essential Tremor After Magnetic Resonance-Guided Focused Ultrasound: A Resting-State Functional MRI Study.

Academic radiology·2026
Same author

Integrative neuromodulation in diabetic foot infections: electroacupuncture-driven macrophage reprogramming and synergy with antimicrobial biomaterials.

Frontiers in cellular and infection microbiology·2026
Same author

Direct targeting for focused ultrasound thalamotomy in the treatment of movement disorders.

Journal of neurosurgery·2026
Same author

Remodelling of body composition surrounding the diagnosis of type 2 diabetes in three longitudinal cohorts.

Diabetologia·2026
Same author

Fabricating Tunable Polyacrylamide Hydrogels To Study Matrix Stiffness Effects On Stem Leydig Cells.

Journal of visualized experiments : JoVE·2026
Same author

Extracellular matrix microarchitecture modulates cellular behavior and extracellular vesicle phenotypes in biomimetic tendon models.

Bioengineering & translational medicine·2026

Related Experiment Video

Updated: Sep 15, 2025

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
08:50

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics

Published on: August 16, 2024

868

The ExoGAN generative AI framework enables extracellular vesicle-based immunotherapy.

Kiley Graim1, Zachary Greenberg1, Tina Salehi Torabi1

  • 1University of Florida.

Research Square
|July 18, 2025
PubMed
Summary

We developed ExoGAN, an AI framework to design novel tumor neoantigens for cancer immunotherapy. ExoGAN-engineered extracellular vesicles effectively activate T cells, improving anti-tumor immunity and enabling precision cancer treatments.

More Related Videos

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells
08:02

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells

Published on: September 23, 2021

2.7K
Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles
08:35

Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles

Published on: January 4, 2012

28.4K

Related Experiment Videos

Last Updated: Sep 15, 2025

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
08:50

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics

Published on: August 16, 2024

868
In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells
08:02

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells

Published on: September 23, 2021

2.7K
Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles
08:35

Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles

Published on: January 4, 2012

28.4K

Area of Science:

  • Immunology
  • Artificial Intelligence
  • Biotechnology

Background:

  • Neoantigens (tumor antigenic peptides presented by MHC-I) are crucial for CD8+ T cell activation in cancer immunotherapy.
  • Current immunotherapies face challenges due to patient-specific tumor heterogeneity and unpredictable T Cell Receptor (TCR) binding properties.
  • Developing novel neoantigens with predictable TCR recognition is essential for effective cancer treatment.

Purpose of the Study:

  • To introduce ExoGAN, a generative AI framework designed to guide the creation of novel tumor antigenic peptides.
  • To engineer extracellular vesicles (EVs) decorated with ExoGAN-designed peptides for enhanced T cell activation and anti-tumor immunity.
  • To improve the predictability and efficacy of cancer immunotherapy through AI-driven neoantigen design.

Main Methods:

  • Developed ExoGAN, a generative adversarial network (GAN) integrating HLA physiochemistry and sequence data for peptide design.
  • Trained ExoGAN on the largest IEDB dataset of HLA peptides to design HLA-A*02:01-targeting peptides.
  • Engineered extracellular vesicles (EVs) to present ExoGAN-designed peptides in MHC complex proteins for targeted delivery and T cell activation.

Main Results:

  • ExoGAN successfully designed novel human neoantigens with improved TCR recognition and T cell activation potential.
  • EVs decorated with ExoGAN-designed peptides demonstrated consistent antigenic presentation to T cell TCRs.
  • Computational and experimental validation confirmed programmable EV agents for effective anti-tumor immunity activation.

Conclusions:

  • The ExoGAN framework enables the design of neoantigens with enhanced TCR recognition and T cell activation capabilities.
  • EV-based delivery of ExoGAN-designed peptides offers a programmable platform for precision cancer immunotherapy.
  • This approach advances mechanistic understanding of neoantigen functionality and accelerates the development of novel immunotherapy agents.